111 related articles for article (PubMed ID: 17123288)
1. Model for end-stage liver disease (MELD) exception for ascites.
Biggins SW; Colquhoun S; Gish RG; Runyon BA
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S88-90. PubMed ID: 17123288
[No Abstract] [Full Text] [Related]
2. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
Freeman RB; Gish RG; Harper A; Davis GL; Vierling J; Lieblein L; Klintmalm G; Blazek J; Hunter R; Punch J
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S128-36. PubMed ID: 17123284
[No Abstract] [Full Text] [Related]
3. Model for end-stage liver disease (MELD) exception guidelines.
Wiesner R; Lake JR; Freeman RB; Gish RG
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-7. PubMed ID: 17123285
[No Abstract] [Full Text] [Related]
4. Model for end-stage liver disease (MELD) exception for polycystic liver disease.
Arrazola L; Moonka D; Gish RG; Everson GT
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S110-1. PubMed ID: 17123287
[No Abstract] [Full Text] [Related]
5. Model for end-stage liver disease (MELD) exception for severe pruritus.
Washburn WK; Gish RG
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S119. PubMed ID: 17123292
[No Abstract] [Full Text] [Related]
6. Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.
McDiarmid S; Gish RG; Horslen S; Mazariegos GV
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S124-7. PubMed ID: 17123278
[No Abstract] [Full Text] [Related]
7. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy.
Ham J; Gish RG; Mullen K
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S102-4. PubMed ID: 17123294
[No Abstract] [Full Text] [Related]
8. Model for end-stage liver disease (MELD) exception for cystic fibrosis.
Horslen S; Sweet S; Gish RG; Shepherd R
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S98-9. PubMed ID: 17123272
[No Abstract] [Full Text] [Related]
9. Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome.
Washburn WK; Gish RG; Kamath PS
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S93-4. PubMed ID: 17123293
[No Abstract] [Full Text] [Related]
10. Model for end-stage liver disease (MELD) exception for primary hyperoxaluria.
Horslen S; Gish RG; McDonald R
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S117-8. PubMed ID: 17123291
[No Abstract] [Full Text] [Related]
11. Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia.
Garcia-Tsao G; Gish RG; Punch J
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S108-9. PubMed ID: 17123286
[No Abstract] [Full Text] [Related]
12. Model for end-stage liver disease (MELD) exception small-for-size syndrome.
Sheiner P; Belghiti J; Gish RG; Miller C
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S120-1. PubMed ID: 17123277
[No Abstract] [Full Text] [Related]
13. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
Pomfret E; Gish RG; Brandhagen D
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
[No Abstract] [Full Text] [Related]
14. Model for end-stage liver disease (MELD) exception for bacterial cholangitis.
Gores GJ; Gish RG; Shrestha R; Wiesner RH
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S91-2. PubMed ID: 17123280
[No Abstract] [Full Text] [Related]
15. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.
Krowka MJ; Fallon MB; Mulligan DC; Gish RG
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S114-6. PubMed ID: 17123283
[No Abstract] [Full Text] [Related]
16. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome.
Fallon MB; Mulligan DC; Gish RG; Krowka MJ
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S105-7. PubMed ID: 17123282
[No Abstract] [Full Text] [Related]
17. Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors.
Punch J; Gish RG
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S122-3. PubMed ID: 17123279
[No Abstract] [Full Text] [Related]
18. Model for end-stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding.
Sheiner P; Gish RG; Sanyal A
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S112-3. PubMed ID: 17123290
[No Abstract] [Full Text] [Related]
19. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.
Gores GJ; Gish RG; Sudan D; Rosen CB;
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S95-7. PubMed ID: 17123289
[No Abstract] [Full Text] [Related]
20. The model for end-stage liver disease comes of age.
Freeman RB
Clin Liver Dis; 2007 May; 11(2):249-63. PubMed ID: 17606205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
